How Raised Revenue Guidance Will Impact Everpure (P) Investors

Simply Wall St · 2d ago
  • Everpure issued new guidance for fiscal 2028, projecting revenue between US$7.0b and US$7.3b after reporting 38% year-over-year growth in Q2 fiscal 2027 and raising its 2027 outlook.
  • The company is accepting lower product margins and temporarily weaker free cash flow to lock in hyperscaler wins and expand its contracted backlog, which reached US$4.1b with 44% year-over-year growth.
  • We will look at how Everpure's investment narrative is reshaped by the ambitious 2028 revenue outlook, which is anchored in hyperscaler demand.
Ride the momentum around Everpure's hyperscaler push and compare it with 88 AI infrastructure stocks that could be building the next leg of AI data demand.

Everpure Investment Narrative Recap

To own Everpure, you need to believe the company can turn strong hyperscaler traction, a US$4.1b contracted backlog and its flash plus software portfolio into a more durable, higher margin platform over time. The new 2028 revenue outlook of US$7.0b to US$7.3b raises the bar but mainly reinforces that hyperscaler demand is the core story.

The near term catalyst is execution on large cloud and AI infrastructure projects while managing supply commitments, product mix and subscription growth. The biggest risk is that heavy spend, lower product margins and volatile hyperscaler volumes compress profitability without a matching step up in recurring software and services contribution.

The most relevant announcement for this story is Everpure’s 2028 revenue guidance of US$7.0b to US$7.3b. This follows Q2 fiscal 2027 revenue growth of 38% and a higher 2027 outlook of US$5.03b to US$5.07b. That guidance leans heavily on hyperscaler wins, including a second top five cloud customer, and a 44% expansion in contracted backlog to US$4.1b.

For you, the key question is whether Everpure can deliver that workload ramp while absorbing lower product margins, higher R&D and negative free cash flow linked to component purchases. Index removal from two Russell small cap benchmarks adds some technical noise, but the operational story still turns on hyperscaler deployment timing, the mix between hardware and Evergreen subscriptions and discipline on long term returns from this capex heavy phase.

Everpure's consensus story points to US$6.1b in revenue and US$671.0m in earnings by 2029, based on analyst assumptions of 15.7% yearly top line growth and an earnings increase of roughly 3x from US$226.3m today.

Uncover why Everpure's fair value indicates a 28% potential downside to its current price, which leaves little room for error.

NYSE:P 1-Year Stock Price Chart
NYSE:P 1-Year Stock Price Chart

Exploring Other Perspectives

Some of the most optimistic analysts focus on hyperscaler customer concentration as a potential catalyst rather than a risk. Before this new Everpure guidance, they were already penciling in about US$6.7b of revenue and US$791.2m of earnings by 2029. You can treat those upbeat forecasts as one end of a wide opinion spectrum that may shift after the latest news.

Explore 7 other Everpure fair value estimates, including one that suggests as much as 192% upside from the current price!

The Verdict Is Yours

Don't just follow the ticker. Dig into the data and build a conviction that's truly your own.

Looking For More Ideas Beyond Everpure?

If the Everpure story has you thinking about portfolio balance and fresh opportunities, it can help to scan a wider field of companies that fit different roles in your mix.

  • For investors who want potential upside without ignoring balance sheet strength, consider reviewing a 7 elite penny stocks with strong financials that may offer higher risk and higher return profiles in smaller businesses.
  • If you prefer quality at a measured entry point, focus on companies that combine solid fundamentals with attractive pricing using a 32 high quality undervalued stocks that meet stricter financial criteria.
  • For those who care most about capital resilience, concentrate on businesses with steadier earnings and healthier finances by screening through a 30 resilient stocks with low risk scores tailored for lower volatility candidates.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.